Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs CarMax, Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while CarMax, Inc trades at $49.79 (market cap $7.21B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 4.3× CarMax, Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while CarMax, Inc pays none. Which is the better fit depends on your goals.
| GEHC | KMX | |
|---|---|---|
Market Cap | $31.07B | $7.21B |
Volume | 3,443,020 | 3,127,971 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $64.22 |
52-Week Low | $59.48 | $30.88 |
Enterprise Value | $39.53B | $24.91B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 49 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
CarMax (KMX) trades at $49.83, down 1.7% on the day, with a bearish technical outlook despite recent earnings beats. The company reported strong Q2 2027 results with EPS of $1.16 beating expectations by 58%, driven by 19.5% revenue growth to $7.9 billion. Valuation metrics show attractive P/S of 0.26x but elevated P/E of 23.97x. Net income margin remains thin at 1.06%, though improving from previous quarters. The stock faces technical resistance at $51-$53 levels with RSI indicating potential oversold conditions.
KMX presents a mixed investment case with strong operational turnaround momentum but significant debt burden and margin pressures. The consensus price target of $60.63 offers 22% upside potential, though analyst sentiment is cautious with 62% hold ratings. Key risks include high leverage (debt-to-assets of 68.16%), cyclical auto market exposure, and execution of the 'Shift into GEAR' strategy. Near-term catalysts include the November strategic update webcast and continued earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
